Besides, this is the first study showing that proliferating CD8 + /TCF1 + T cells and CD163 + /PD-L1 + macrophages are independent prognostic markers for DFS in patients with breast carcinoma (Table 2, 3, Supplementary Table 9). Here, CD163 is linked to breast carcinoma.